Jul. 11, 2019
New Zealand will hold a hearing on Monday 22 July 2019 to discuss an application submitted by Bayer New Zealand Limited on importing for release a new fungicide, Vimoy Iblon, to New Zealand.
The active ingredient in Vimoy Iblon, isoflucypram, has not yet been approved in any country. This active ingredient is a Succinate DeHydrogenase Inhibitor (SDHI) fungicide. Bayer intends to market its use to control scald, net blotch, Ramularia leaf spot in barley, leaf rust in barley and wheat, stripe rust in wheat and triticale, speckled leaf blotch in wheat and stem rust in ryegrass crops.
It is also said to be able to treat four arable diseases in New Zealand: Septoria tritici and leaf rust which infect wheat; Ramularia leaf spot that infects barley, and stem rust which infects ryegrass seed crops.
Information provided by all parties to this process will be considered by a decision-making committee, who ultimately decide whether the substance can be imported or manufactured for use in New Zealand, and the controls (rules) that may be necessary to manage any environmental or human health concerns.